COURT-RULING ·Filed Mar 30, 2026
Court ruling (district)
Actionable Insight • Neutral
Monitor for subsequent filings or public statements from Moderna regarding the litigation. Given the involvement of Northwestern University, this could relate to intellectual property, but without further details, material impact cannot be assessed.
Final — all horizons settled through T+60d
MRNA ▲ +25.45% at T+60d
NEUTRAL call ✓ call won +25.45% · α vs SPY +9.43% · entry $48.16 → $60.42
T+1d
+5.40%
call +5.40% · α +2.51%
$50.76
settled 6mo ago
T+5d
+3.70%
call +3.70% · α -0.60%
$49.94
settled 6mo ago
T+20d
-2.31%
call -2.31% · α -14.90%
$47.05
settled 5mo ago
T+60d
+25.45%
call +25.45% · α +9.43%
$60.42
settled 3mo ago
Price Chart
Loading chart...
Executive Summary
Analysis based on filing metadata only — document content was unavailable
Court Ruling Details
Court
United States District Court for the District of Delaware
Court Level
District
Case Type
other
Ruling Type
other
Outcome
NULL
Will It Be Appealed?
N/A (final)
Precedent Risk
LOW
Key Facts
- Case: Northwestern University v. Moderna, Inc. et al, filed in U.S. District Court for the District of Delaware
- Date filed: 2026-03-30
- Status: unknown
- Nature of suit or ruling details not available in provided text
Financial Impact
Unknown — no financial figures or ruling details provided
Risk Factors
- Potential IP or patent dispute with academic institution, which could affect future product development if substantiated
- Risk of future financial exposure or injunction if the case proceeds and ruling is adverse
Market Snapshot
Exchange
Nasdaq
Sector
Biological Products, (No Diagnostic Substances)
Analyst Consensus
10% bullish (30 analysts)
Investment Themes
Biotech & Drug Discovery
Documents Analyzed
This report is based on 1 court opinion from CourtListener.
| Document | Accession Number |
|---|---|
| COURT-RULING Data (Synthetic) | court-2eno758p-MRNA |
18 reports for MRNA
80% Hit rate best @ T+60▲ +14.15%
Filters
Rows
| Type | Now | ||||
|---|---|---|---|---|---|
Sep 30, 2026 2d ago | ANALYST-DOWNGRADE | — | awaiting T+5 | — | — |
Sep 3, 2026 29d ago | ANALYST-DOWNGRADE | $148.87 $143.97 | ▲ +3.29% | ▲ +2.14% | $190.01 (−27.63%) |
Aug 31, 2026 4w ago | Court Ruling | $140.19 $140.33 | ▼ −0.10% | ▼ −0.24% | $190.01 (−35.54%) |
Aug 25, 2026 5w ago | ANALYST-UPGRADE | $158.83 $154.27 | ▼ −2.87% | ▼ −2.33% | $190.01 (+19.63%) |
Aug 19, 2026 6w ago | ANALYST-UPGRADE | $174.38 $149.66 | ▼ −14.18% | ▼ −13.79% | $190.01 (+8.96%) |
Aug 5, 2026 8w ago | 144 | $56.26 $63.67 | ▼ −13.18% | ▼ −12.83% | $190.01 (−237.77%) |
Jul 31, 2026 9w ago | 8-K | $54.82 $59.17 | ▲ +7.94% | ▲ +4.42% | $190.01 (+246.61%) |
Jul 10, 2026 11w ago | 3 | $67.01 $61.82 | ▼ −7.75% | ▼ −6.96% | $190.01 (+183.55%) |
Jul 8, 2026 12w ago | 8-K | $73.80 $67.44 | ▼ −8.62% | ▼ −9.48% | $190.01 (+157.47%) |
Jun 18, 2026 15w ago | 144 | $63.96 $59.75 | ▼ −6.58% | ▼ −4.92% | $190.01 (+197.08%) |
Showing 10 of 18
US Market Status
Market Closed — Opens Mon (65h 5m)
Subscribe to SecBot
Get Real-Time Court Ruling Intelligence
Market-moving court rulings analyzed within minutes. Patent verdicts, antitrust decisions, class certifications, and more — parsed and scored by AI.
Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access